Administration of a Standardized Plasma-Protein Solution (Biseko®) in High-Risk Patients With Systemic Inflammatory Response Syndrome: Influence on Cytokine Levels and Survival
Critical Care - United Kingdom
doi 10.1186/cc6449
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2008
Authors
Publisher
Springer Science and Business Media LLC